David S. Block

Form D signer

David S. Block

CEO and President at Gliknik

Form D signer

Capital raised by Gliknik

$16.3M+$11.0M latest round

2 Form D filings · first filed Nov 2024 · Baltimore, MD

CURRENT ROLE: CEO and President
SECTOR: Biotech
COMPANY FILINGS: 2
TEAM ON FILE: 2
FOUNDED: —
30D INTEREST: 1 ↗

Career

1 company on file

GliknikBiotech · Baltimore, MDsince Nov 2024

CEO and President

Signatory on Gliknik's Form D filings · $16.3M raised across 2

Company filings

via EDGAR · Form D for Gliknik2

DateCompanyFormAmountRole on filing

Aug 15, 2025GliknikForm D+$11.0MCEO and President

Form DAug 15, 2025 · Gliknik+$11.0Mas CEO and President

Nov 6, 2024GliknikForm D/A+$5.3MCEO and President

Form D/ANov 6, 2024 · Gliknik+$5.3Mas CEO and President

Overview

Last filing Aug 15, 2025

David S. Block is on file as CEO and President at Gliknik in Baltimore, MD. Gliknik has 2 Form D filings on record, $16.3M raised in total. David S. Block appears as a signatory on the company's filings.

Teammates

Gliknik · 1

David BroserDirector

Products

Gliknik · 1

GL-2045Biologics

GL-2045 is a recombinant Fc fusion protein developed to emulate the therapeutic effects of intravenous immunoglobulin (IVIG), providing a potentially more effective option for treating various autoimmune diseases.